These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 30715571

  • 21. [Selective chemoembolization with adriamycin-Urografin-Lipiodol in the treatment of hepatocarcinoma].
    Brahm J, Chesta J, Gaínza V, Arriagada V.
    Rev Med Chil; 1990 Oct; 118(10):1135-7. PubMed ID: 1967109
    [Abstract] [Full Text] [Related]

  • 22. Iodized oil in the treatment of hepatocellular carcinoma.
    Bhattacharya S, Novell JR, Winslet MC, Hobbs KE.
    Br J Surg; 1994 Nov; 81(11):1563-71. PubMed ID: 7827876
    [Abstract] [Full Text] [Related]

  • 23. Hepatic artery injection of I-131-labeled lipiodol. Part I. Biodistribution study results in patients with hepatocellular carcinoma and liver metastases.
    Raoul JL, Bourguet P, Bretagne JF, Duvauferrier R, Coornaert S, Darnault P, Ramée A, Herry JY, Gastard J.
    Radiology; 1988 Aug; 168(2):541-5. PubMed ID: 2839866
    [Abstract] [Full Text] [Related]

  • 24. Intraarterial HCC therapy with I-131-Lipiodol.
    Risse JH, Grünwald F, Kersjes W, Strunk H, Caselmann WH, Palmedo H, Bender H, Biersack HJ.
    Cancer Biother Radiopharm; 2000 Feb; 15(1):65-70. PubMed ID: 10740654
    [Abstract] [Full Text] [Related]

  • 25. Preparation and biodistribution of rhenium-188 ECD/Lipiodol in rats following hepatic arterial injection.
    Luo TY, Hsieh BT, Wang SJ, Lin WY, Lee TW, Shen LH, Su MJ.
    Nucl Med Biol; 2004 Jul; 31(5):671-7. PubMed ID: 15219287
    [Abstract] [Full Text] [Related]

  • 26. Superselective intra-arterial radiometabolic therapy with I-131 lipiodol in hepatocellular carcinoma.
    Maini CL, Scelsa MG, Fiumara C, Tofani A, Sciuto R, Tipaldi L, D'Annibale M, Santoro E.
    Clin Nucl Med; 1996 Mar; 21(3):221-6. PubMed ID: 8846568
    [Abstract] [Full Text] [Related]

  • 27. Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres.
    Garin E, Rolland Y, Laffont S, Edeline J.
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):559-75. PubMed ID: 26338177
    [Abstract] [Full Text] [Related]

  • 28. Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results.
    Garin E, Lenoir L, Rolland Y, Edeline J, Mesbah H, Laffont S, Porée P, Clément B, Raoul JL, Boucher E.
    J Nucl Med; 2012 Feb; 53(2):255-63. PubMed ID: 22302962
    [Abstract] [Full Text] [Related]

  • 29. Effects of lipiodol retention on MRI signal intensity from hepatocellular carcinoma and surrounding liver treated by chemoembolization.
    De Santis M, Alborino S, Tartoni PL, Torricelli P, Casolo A, Romagnoli R.
    Eur Radiol; 1997 Feb; 7(1):10-6. PubMed ID: 9000387
    [Abstract] [Full Text] [Related]

  • 30. [Lipiodolized angiography in hepatocellular carcinomas. Contribution of iodine-131-labelled lipiodol].
    Raoul JL, Duvauferrier R, Bourguet P, Bretagne JF, Coornaert S, Darnault P, Deugnier Y, Herry JY, Gastard J.
    J Radiol; 1986 Nov; 67(11):797-801. PubMed ID: 3027321
    [Abstract] [Full Text] [Related]

  • 31. Personalized dosimetry with intensification using 90Y-loaded glass microsphere radioembolization induces prolonged overall survival in hepatocellular carcinoma patients with portal vein thrombosis.
    Garin E, Rolland Y, Edeline J, Icard N, Lenoir L, Laffont S, Mesbah H, Breton M, Sulpice L, Boudjema K, Rohou T, Raoul JL, Clement B, Boucher E.
    J Nucl Med; 2015 Mar; 56(3):339-46. PubMed ID: 25678490
    [Abstract] [Full Text] [Related]

  • 32. Preparation and therapeutic evaluation of (188)Re-thermogelling emulsion in rat model of hepatocellular carcinoma.
    Shih YH, Lin XZ, Yeh CH, Peng CL, Shieh MJ, Lin WJ, Luo TY.
    Int J Nanomedicine; 2014 Mar; 9():4191-201. PubMed ID: 25214783
    [Abstract] [Full Text] [Related]

  • 33. Lipiodol enhanced CT scanning in assessment of hepatocellular carcinoma.
    Raby N, Karani J, Michell M, Gimson A, Nunnerley H, Williams R.
    Clin Radiol; 1989 Sep; 40(5):480-5. PubMed ID: 2551562
    [Abstract] [Full Text] [Related]

  • 34. Role of yttrium-90 in the management of unresectable hepatocellular carcinoma and hepatic metastases.
    Kousik V, Promila P, Verma R, Gupta A.
    Indian J Gastroenterol; 2016 May; 35(3):179-85. PubMed ID: 27185180
    [Abstract] [Full Text] [Related]

  • 35. Radioembolization of Hepatocellular Carcinoma with Built-In Dosimetry: First in vivo Results with Uniformly-Sized, Biodegradable Microspheres Labeled with 188Re.
    De La Vega JC, Esquinas PL, Rodríguez-Rodríguez C, Bokharaei M, Moskalev I, Liu D, Saatchi K, Häfeli UO.
    Theranostics; 2019 May; 9(3):868-883. PubMed ID: 30809314
    [Abstract] [Full Text] [Related]

  • 36. Intraarterial Hepatic SPECT/CT Imaging Using 99mTc-Macroaggregated Albumin in Preparation for Radioembolization.
    Gates VL, Singh N, Lewandowski RJ, Spies S, Salem R.
    J Nucl Med; 2015 Aug; 56(8):1157-62. PubMed ID: 26089551
    [Abstract] [Full Text] [Related]

  • 37. [Lipiodol chemoembolization in the treatment of hepatic carcinoma. Our experience].
    Padula G, Derosas M, Carpanese L, Pisano I, Deiana A, Serra G, Trignano M.
    Minerva Chir; 1993 Sep 15; 48(17):881-5. PubMed ID: 8290123
    [Abstract] [Full Text] [Related]

  • 38. Lipiodol enhanced CT scanning of malignant hepatic tumors.
    Eurvilaichit C.
    J Med Assoc Thai; 2000 Apr 15; 83(4):398-406. PubMed ID: 10808700
    [Abstract] [Full Text] [Related]

  • 39. A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.
    Kokabi N, Galt JR, Xing M, Camacho JC, Barron BJ, Schuster DM, Kim HS.
    J Vasc Interv Radiol; 2014 Feb 15; 25(2):277-87. PubMed ID: 24461133
    [Abstract] [Full Text] [Related]

  • 40. Comparison of positron emission tomography and bremsstrahlung imaging to detect particle distribution in patients undergoing yttrium-90 radioembolization for large hepatocellular carcinomas or associated portal vein thrombosis.
    Padia SA, Alessio A, Kwan SW, Lewis DH, Vaidya S, Minoshima S.
    J Vasc Interv Radiol; 2013 Aug 15; 24(8):1147-53. PubMed ID: 23792126
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.